Digital CDx (DCDx)

Revolutionizing Cancer Diagnostics with AI-Powered Gene Mutation Prediction

Digital CDx analyzes CT scans and clinical information to provide rapid and accurate gene mutation identification.

Key Benefits

Non-invasive:

No additional biopsy required.

Fast & Accurate:

Instant identification of EGFR mutations.

Flimination of Tissue Limitations:

Overcoming challenges associated with insufficient or degraded tissue samples.

Clinical Value & Use Cases

Use Cases: Patients with suspected lung cancer needing genetic testing.

　・ Situations where biopsies are difficult or infeasible.

　・ Enhancing precision oncology by integrating AI into clinical workflows.

Integration & Implementation

Deployment Options:

　・ Cloud-based API

　・On-premise deployment for hospitals

Compatibility:

　・Works with standard DICOM formats and integrates with PACS.